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ABSTRACT
Respiratory tract infections with Streptococcus pneumoniae are an important cause of morbidity and
mortality among military personnel. A sensitive method is needed to determine the prevalence of
S. pneumoniae colonisation in respiratory secretions, as well as its role in pneumonia without an
established aetiology. This study investigated the efficacy of two PCR assays in screening military
personnel for S. pneumoniae colonisation. Nasopharyngeal swabs were obtained from 200 military
personnel and tested for S. pneumoniae by culture and PCR. S. pneumoniae was cultured from three
(1.5%) of the 200 samples. PCR for the lytA gene detected S. pneumoniae in 11% of the samples, while
PCR for the pneumolysin gene detected S. pneumoniae in 3% of the samples. The sensitivity and negative
predictive values were 100% for both PCR assays when compared to culture; the specificity and positive
predictive values for the lytA PCR were 90.4% and 13.6%, respectively, compared with 98.5% and 50%,
respectively, for the pneumolysin gene PCR. It was concluded that respiratory tract colonisation of
military personnel with S. pneumoniae can be identified rapidly and reliably by PCR assays. The use of
this technique may greatly enhance the ability to identify a microbial aetiology for pneumonia when
compared with conventional culture methods.
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INTRODUCTION
Streptococcus pneumoniae remains one of the most
frequent bacterial pathogens isolated from cases
of community-acquired pneumonia, sinusitis,
otitis media and meningitis, and colonises the
upper respiratory tract of 9–43% of healthy
children [1]. A previous study of healthy military
trainees revealed that only 1.2% were colonised
with S. pneumoniae [2]. However, there are reports
of an alarming increase in the rate of respiratory
infectious disease without a clearly defined aeti-
ology among military personnel [3]; indeed,
respiratory disease accounts for 25–30% of hos-
pitalisations caused by infectious disease among
US military personnel [4]. Crowded living condi-
tions and exposure to respiratory pathogens in
endemic disease areas have placed newly mobi-
lised troops at high risk for epidemics of respir-
atory disease [5–8].
During the Gulf War, there was a high inci-
dence of respiratory disease of undetermined
aetiology among both US and UK soldiers [9,10].
Unexplained cases of pneumonia among military
populations during Operation Iraqi Freedom may
reflect the possibility of under-diagnosis of cases
of pneumococcal pneumonia [11]. A previous
study of healthy military recruits has suggested
that colonisation with S. pneumoniae is low [2].
Among military personnel with acute respiratory
disease, the rate of recovery of S. pneumoniae was
reported to be only 7.3% [12]. Kadioglu et al. [13]
reported that rates of colonisation of the upper
respiratory tract in healthy adults can vary from
5% to 70%, depending on the age and the
environment of the host. However, most studies
evaluating colonisation have focused on paediat-
ric populations, and have been hindered by a
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limited availability of adequate specimens and
the inherent restrictions of conventional micro-
biological culture for the isolation of pathogens.
These restrictions include sampling deficiencies,
the number and viability of organisms, and
bacterial overgrowth by commensal organisms.
PCR data from an experimental model of infected
rats revealed a significantly higher rate of naso-
pharyngeal colonisation for S. pneumoniae when
compared to conventional microbiological
cultures [14]. Therefore, the present study used
real-time PCR to detect pneumococcal DNA in
samples from healthy members of the Michigan
Air National Guard (ANG), and compared the
results to those obtained by conventional micro-
biological culture, in order to determine the
prevalence of S. pneumoniae colonisation.
MATERIALS AND METHODS
Study population
The present field study included 200 members of the Michigan
ANG at Selfridge Air Force Base, Mt Clemens, MI, USA. The
study participants were healthy individuals with no co-morbid
medical conditions. Samples were obtained over a 2-day
period before deployment to Operation Iraqi Freedom as
individuals moved through a mobility line at the ANG base.
Informed consent was obtained from each volunteer. Individ-
uals were excluded from the study if they were on active duty
or if they were experiencing any upper respiratory tract
infection. In addition, all participants were given an epidemi-
ological questionnaire that requested the following information:
age, gender, race, postal (zip) code, number of individuals
living in the same residence and their ages, tobacco use,
number of children attending childcare facilities, number of
hospitalisations in the previous 12 months, current medica-
tions, and antibiotic use in the previous 12 months. The study
was approved by the Institutional Review Board of St John
Hospital and Medical Center, Selfridge Air National Guard
Base, and the Michigan ANG State Surgeon General.
Sample collection and processing
Two nasopharyngeal samples were obtained from each parti-
cipant, one from each nares, using rayon tip swabs (Copac,
Corona, CA, USA). Each swab was inserted into the posterior
nasopharynx and rotated 180. The samples were placed in
1 mL of skim milk–tryptone–glucose–glycerine (STGG) trans-
port medium at the ANG base and were maintained on ice for
up to 8 h until delivery to the laboratory. At the laboratory, the
samples were stored for up to 8 weeks at )70C until thawed
for processing. STGG medium was prepared as described
previously [15], dispensed into 1-mL vials, and then stored at
)70C until use. Transfer of swabs to STGG medium before
plating has been shown in previous studies to yield signifi-
cantly enhanced recovery of pneumococci when compared
with direct plating [15,16]. Each batch of STGG medium was
tested for sterility by plating an entire vial on a blood agar
plate. Another vial of STGG medium was used as a sample
for DNA extraction and PCR to verify the absence of
contamination of the medium.
At the time of testing, vials were thawed at room tempera-
ture and vortexed for 30 s. A 100-lL sample was spread on
two plates: (i) Columbia agar containing lysed horse blood 5%
v ⁄v with gentamicin 5 mg ⁄L; and (ii) Columbia agar contain-
ing lysed horse blood 5% v ⁄v with gentamicin 5 mg ⁄L
and penicillin 0.1 mg ⁄L (the penicillin was added to detect
penicillin-resistant S. pneumoniae). All plates were incubated at
37C in CO2 5% v ⁄v for 24–72 h. The remaining sample was
used for DNA extraction (QIAamp; Qiagen, Valencia, CA,
USA). During the 72-h growth period, the plates were
examined daily; colonies resembling S. pneumoniae were
removed, propagated and further identified. Colonies showing
a-haemolysis typical of S. pneumoniae were confirmed using
optochin disks and bile solubility testing.
Real-time PCR
Real-time PCR was performed using the Gene Amp 5700
(Applied Biosystems, Foster City, CA, USA), with two com-
mon S. pneumoniae genes, lytA and the pneumolysin gene, as
targets. The primers and TaqMan probe for the pneumolysin
gene of S. pneumoniae (GenBank accession no. M17717) were
designed with Primer Express Software v.2.0 (Applied Biosys-
tems). The nucleotide sequence for the forward primer was
5¢-CTACCAACGACAGTCGCCTCTA (positions 397–418) and
the sequence for the reverse primer was 5¢-ATTAT
TCTCTAACAAGGTCTCATCCACTAC (positions 464–435).
The TaqMan probe sequence was 5¢-6-carboxy-fluorescein
(FAM)-CCTGGAGCACTTCT3¢MGB (positions 420–433). The
pneumolysin master mix contained 2 · TaqMan Universal
Master Mix (Applied Biosystems), with 200 nM both primers
and 250 nM probe. The lytA gene primers and Taqman probe
[17] were: forward primer, 5¢-ACGCAATCTAGCAGA
TGAAGC (positions 306–326); reverse primer, 5¢-TGTTT
GGTTGGTTATTCGTGC (386–406 bp); and Taqman probe,
5¢-(FAM)-TTTGCCGAAAACGCTTGATACAGGG-(TAMARA)
(330–354 bp). The lytA master mix contained 2 · Taqman
Universal Master Mix with 900 nM both primers and 250 nM
probe. All primers and probes were synthesised by Applied
Biosystems. Thermocycler settings comprised 50C for
2 min, 95C for 10 min, and 40 cycles of 95C for 15 s and
60C for 60 s.
Controls
S. pneumoniae ATCC 49619 was used as the positive control
and was included in each run at the following serial dilutions
(pg ⁄ lL) of bacterial DNA: 105, 104, 103, 102, 10, 1, 0.5 and 0.1.
Five other ATCC strains were chosen to represent probable
upper respiratory tract flora, other than S. pneumoniae, and
were used as negative controls: Streptococcus sanguis
ATCC 10556, Moraxella catarrhalis ATCC 8176, Streptococcus
oralis ATCC 9811, Haemophilus influenzae ATCC 49247 and
Streptococcus mitis ATCC 15914. Water was used as a negative
template control in each experiment for the purpose of reagent
control. An extracted sample of STGG was also run as a
negative control for the purpose of broth control. In addition,
the possibility of inhibitory substances in each patient sample
was assayed by spiking an aliquot of each sample with 105 pg
of ATCC 49619 DNA.
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RESULTS
The demographical data for the 200 military
personnel are summarised in Table 1. The popu-
lation was predominantly male (87%), Caucasian
(78%), and non-smokers (76%). The mean age
was 39.8 ± 9.2 years, with 11.1% having a house-
hold member attending a childcare facility. Five
per cent of the participants had been hospitalised
and 19.9% had taken antibiotics during the
preceding 12 months.
Microbiological culture revealed that three of
200 samples (1.5%; 95% CI 0.51–4.3) were posit-
ive for S. pneumoniae (Table 2). All three of these
samples had 2+ growth, corresponding to 25
colonies in the second isolation quadrant. Real-
time PCR yielded 22 (11%) and six (3%) positive
samples according to the lytA and pneumolysin
PCRs, respectively. The calculated test character-
istics for the lytA and pneumolysin targets are
summarised in Table 2.
As a standard curve was prepared for each
assay, it was possible to quantify the amount of
DNA present in the positive samples. The sensi-
tivity of the PCR assays with serial dilutions of
S. pneumoniae ATCC 49619 DNA was 1 pg ⁄lL for
the pneumolysin gene and 0.5 pg ⁄ lL for the lytA
gene. The samples positive for the pneumolysin
gene were in the range 2.6–10.6 pg (mean Ct
(threshold cycle) was 31.8 ± 1.2), while the sam-
ples positive for the lytA gene were in the range
0.5–10.9 pg (mean Ct 33.1 ± 1.4). The amount of
DNA detected in the lytA-positive samples was
an average of 70% lower for five of six concordant
positive samples (pneumolysin-positive, mean
5.6 ± 3.3 pg; lytA-positive, mean 1.5 ± 2.2 pg).
The remaining concordant sample contained
10.6 pg of DNA according to the pneumolysin
PCR, and 10.9 pg according to the lytA PCR. No
inhibitors were detected in any of the clinical
specimens analysed, probably because the DNA
was extracted from the samples using the QIA-
amp DNA Mini Kit, which contains purification
steps to remove PCR inhibitors.
DISCUSSION
The problem of lower respiratory tract infections
among military personnel has been highlighted
by the recent operations in Iraq, but numerous
epidemiological studies suggest that this is not a
new phenomenon [3–6,9,10,12]. In the present
study, real-time PCR for two gene targets, lytA
and the pneumolysin gene, proved to be highly
sensitive (100%) and specific (90.4%) for the
detection of S. pneumoniae in nasopharyngeal
secretions from healthy ANG members. Although
Table 1. Demographical data for the 200 military recruits
included in the studya
Parameter
Gender
Male 174
Female 26
Age in years (mean ± SD) 39.8 ± 9.2, range 20–55 years
Number living in the same residence 3.05 ± 1.3; range 0–6
Ethnic group
African-American 26
Caucasian 156
Hispanic 5
Native American 5
Other 8
Cigarette smoking
Yes 47
Formerly 38
Packs ⁄day 0.82 ± 0.57
Never 111
Use of childcare facilities
Yes 21
No 167
Recent hospitalisation
Yes 10
No 179
Use of antibiotics in the last 12 months
Yes 38
No 153
Unsure 3
aResponses totalling <200 indicate that some individuals did not answer a
particular question.
Table 2. Comparison of conventional microbiological culture with real-time PCR
Culture
Real-time PCR
lytA target Pneumolysin target
Positive Negative Positive Negative
Positive (n = 3) 3 0 3 0
Negative (n = 197) 19 178 3 194
Sensitivity 100% (95% CI 43.9–100%) Sensitivity 100% (95% CI 43.9–100%)
Specificity 90.4% (95% CI 85.4–93.7%) Specificity 98.5% (95% CI 95.6–99.5%)
PPV 13.6% (95% CI 4.8–33.3%) PPV 50% (95% CI 18.8–81.2%)
NPV 100% (95% CI 97.9–100%) NPV 100% (95% CI 48.1–100%)
PPV, positive predictive value; NPV, negative predictive value.
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the real-time PCR was highly sensitive for both
targets, the small number of observations resulted
in broad 95% CI values. The negative predictive
value (100%) was also excellent, but the positive
predictive value was only 13.6% for the lytA
target. This low yield was related to the compar-
ison with conventional microbiological culture
techniques, which are intrinsically less sensitive
than nucleic acid amplification techniques. The
low yield from culture may also be a conse-
quence of the small number of organisms present
in the samples studied. For this reason, a broth
enrichment step should be included in future
studies to improve the yield of culture. Another
explanation for the discordant yield between
culture (negative) results and PCR (positive)
results could be previous use of antimicrobial
agents. However, none of the individuals studied
was receiving antimicrobial therapy at the time of
the study, and only one individual with a negat-
ive culture and a lytA-positive PCR assay had
received an antimicrobial agent during the pre-
ceding 12 months. Real-time PCR has the addi-
tional advantage of being completed within
1 day, so that results are available considerably
sooner than with conventional microbiological
methods. Nevertheless, culture techniques are
still required in order to perform antimicrobial
susceptibility testing.
The lower limit of detection of the real-time
PCR approach was found to be as little as 0.5 pg
of total DNA. It would therefore be expected that
organisms showing <25 colonies on culture
would be identified readily by real-time PCR.
Two different S. pneumoniae targets were used in
the present study to increase the sensitivity of
real-time PCR. All three culture-positive speci-
mens were also positive by both PCR assays. The
lytA PCR detected smaller quantities of DNA than
the pneumolysin PCR, which may account for the
greater number of positives identified by the lytA
PCR. The lower positive predictive value of the
lytA gene PCR may reflect reactivity of the
pneumolysin PCR with targeted pneumolysin
homologues from other microorganisms, e.g.,
other a-haemolytic respiratory streptococci. There
is also the possibility that the lytA target identifies
sequences that the pneumolysin target fails to
identify, leading to a better overall detection rate.
There are also reports of organisms related to
S. mitis that possess genes capable of expressing
pneumolysin, which is usually associated with
S. pneumoniae [18]. However, this was not seen in
the present study, since samples from three
individuals yielded S. mitis by culture, but were
negative according to both PCR assays. It is still
not clear which PCR target is preferable, but the
lytA target yielded more positive results than the
pneumolysin target.
Use of the lytA gene for specific identification of
S. pneumoniae has been advocated as a means of
differentiating S. pneumoniae from related strains
of the S. mitis group [17,19]. However, use of the
lytA gene to identify S. pneumoniae remains con-
troversial, as there is still the possibility that it also
identifies genetically related organisms, e.g.,
S. mitis or S. oralis [20]. However, this problem
was not encountered in the present study, and
Obregon et al. [21] demonstrated the absence of
lytA in 70 isolates of S. mitis [21]. The ATCC
control strains of S. sanguis,M. catarrhalis, S. oralis,
S. mitis and H. influenzae used in this study were
detected by the lytA and pneumolysin primers
only when 105 and 104 pg ⁄lL of DNA were used,
i.e., 1000-fold greater than the highest concentra-
tions detected in the samples taken from the
military personnel in the present study (10.9 pg ⁄
lL). Thus, although specificity could, in theory, be
a limitation, the observations in the present study
suggest that the real-time PCR assay for the two
S. pneumoniae targets was highly specific.
The detection of S. pneumoniae DNA in 11% of
healthy military personnel immediately before
deployment suggests that S. pneumoniaemay have
a more important role in the aetiology of respir-
atory disease than was previously suspected,
based on the low prevalence of colonisation
detected by conventional culture techniques. The
relatively high limit of detection of conventional
culture, compared with PCR, may have led to a
failure to recognise the ability of S. pneumoniae to
colonise young adults, middle-aged patients and
military personnel. The present study only
searched for colonising strains, which may or
may not be identical to strains that cause infec-
tion, and the application of the PCR-based
approach is currently uncertain. However, the
information provided may be an important tool
for studying the epidemiology of S. pneumoniae
and ⁄ or possible infections. The test cannot be
used at this time to determine whether military
personnel should be treated or isolated.
The results of the present study suggest
that S. pneumoniae may be under-recognised
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seven-fold in terms of colonisation of the respir-
atory tract in military personnel when conven-
tional microbiological techniques are employed.
The present study was limited by the small
sample size, and the role of real-time PCR in
detecting infectious agents in sputum and other
lower respiratory tract samples requires further
evaluation. Nevertheless, this approach has the
potential for improving understanding of the
epidemiology of S. pneumoniae.
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